A multidisciplinary podcast for healthcare professionals who provide cancer care!
San Diego, CA
Joined November 2024
- Tweets313
- Following732
- Followers291
- Likes689
BackTable Tumor Board retweeted
Thank you 🙏 @TODAYshow for telling the ❤️
story of our amazing and courageous friend
and colleague @rachnatshroff @UAZCancer
We miss her and will continue to add to her
legacy @asco @curecc of fighting GI cancer
today.com/video/remembering-…
Always a pleasure!! 🙌🏼
Really excited to share a podcast I recorded with @Kate_Baker_MD @geoffreybuckle for HER2-amplified gastroesophageal cancer!
What makes it even more exciting is that a great new therapy mentioned in this podcast, tislelizumab + zanidatamab + chemotherapy, has now been approved by FDA as a first-line therapy. Given zanidatmab was shown to be superior to trastuzumab in this study, I'd use this new regimen for almost all 1L HER2-amplified advanced GEA.
Thanks @_backtableONC @AaronFrittsMD @jgong15 for invitation. It was a fun weekend at San Diego!
@DaniCastilloMD @Ahn_Daniel_Onc @IbrahimSahinMD1
#HERIZON
BackTable Tumor Board retweeted
#1L therapies in #HER2-positive advanced #GEJ #gastric cancer is a rapidly evolving space. Great insight from @geoffreybuckle @ronanhsieh @Kate_Baker_MD on this latest @_backtableONC episode
@AaronFrittsMD @DaniCastilloMD @_backtable @_backtableIND @BTWomensHealth @_backtableENT
HER2-positive gastroesophageal cancer has more first-line options than ever and very few head-to-head answers. 🧬
Dr. Geoffrey Buckle (@geoffreybuckle) and Dr. Ronan Hsieh (@ronanhsieh) join Dr. Kate Baker (@Kate_Baker_MD) on first-line choice, oligoprogression, HERIZON-GEA-01, rebiopsy and lung toxicity on trastuzumab deruxtecan.
Watch the full episode on the BackTable App: backtable.com/shows/tumor-bo…
#ONC86 #GastricCancer #EsophagealCancer #HER2 #GIOncology @TNOncology @UCSFCancer @ProvSwedish @theNCI
BackTable Tumor Board retweeted
These algorithms are incredibly helpful for unpacking best practices buried in manuscripts and institutional knowledge.
⭐️ Open Medicine Algorithm Spotlight ⭐️
Daraxonrasib Toxicity Prevention and Management in Pancreatic Cancer from @DrShubhamPant and
@GIcancerDoc:
myopenmedicine.com/algorithm…
HER2-positive gastroesophageal cancer has more first-line options than ever and very few head-to-head answers. 🧬
Dr. Geoffrey Buckle (@geoffreybuckle) and Dr. Ronan Hsieh (@ronanhsieh) join Dr. Kate Baker (@Kate_Baker_MD) on first-line choice, oligoprogression, HERIZON-GEA-01, rebiopsy and lung toxicity on trastuzumab deruxtecan.
Watch the full episode on the BackTable App: backtable.com/shows/tumor-bo…
#ONC86 #GastricCancer #EsophagealCancer #HER2 #GIOncology @TNOncology @UCSFCancer @ProvSwedish @theNCI
BackTable Tumor Board retweeted
To add, one of my former @CedarsSinai post-docs, Dr. Muranaka, brilliantly reviewed in @Cancers_MDPI how Gln supplementation could be a viable alternative to the convention of Gln deprivation as an #anticancer strategy #metabolicintervention
mdpi.com/2072-6694/16/5/1057
@OncoAlert
BackTable Tumor Board retweeted
Thanks @montypal @DrJZell @christine_lovly @MOASC_Office for this great initiative & taking on one of our own @CedarsSinai #PTSP heme/onc fellows Dr. David Shia - the future is bright under this stellar mentorship panel! @kor_shah @AnthonyNguyenMD @Adam_Weiner535 @DaniCastilloMD
We were so excited to kick off our very first @MOASC_Office NextGen Leadership Program at @cityofhope ! Aimed at #hematology/#oncology fellows, we brought together faculty from @UCIrvine (@DrJZell), @cityofhope (@christine_lovly) & representatives from #communityoncology (@ashkanlashkari) to offer practical tips on navigating those first couple of years out.
To our inaugurual class of fellows - @kor_shah (@cityofhope), #DrJonathanBoiarsky (@UCLAHealthJCCC), #DrAllisonReichl (@UCIrvine), @doclirui (@UCLAHealthJCCC), #DrDavidShia (@CedarsSinaiMed), #DrChristopherGrant (@UCSDCancer) - I hope you enjoyed Session 1! Get geared up for Session 2 with a new slate of faculty.
@hoperugo @The_real_Vora @minasedrakmd @ChawlaNeal @SurvivingMD @JCohenMD @PatelOncology
How do you approach head and neck squamous cell carcinoma with extensive nodal disease but a low-volume primary tumor?
This week’s Case Highlight features Drs. Dylan Roden, Ravindra Uppaluri (@DrUppaluri), and Adam Luginbuhl discussing treatment considerations for T2N3 head and neck squamous cell carcinoma, including the role of immunotherapy and surgical management.
Explore this case and more clinical discussions in the BackTable App: backtable.com/shows/tumor-bo…
#HeadAndNeckCancer #ENT #Oncology #Immunotherapy @_backtableENT @Kate_Baker_MD
The hardest decision in localized upper GI cancer is not how to operate. It is what happens in the four months before the operation.
Dr. Kate Baker (@Kate_Baker_MD) asks Dr. Dani Castillo (@DaniCastilloMD) and Dr. Alexandra Gangi (@AGangiMD) what they each need before a plan exists in esophageal, GEJ and gastric cancer, and where they still disagree. 📷
Watch the full episode on the BackTable App: backtable.com/shows/tumor-bo…
#ONC85 #UpperGICancer #GastricCancer #EsophagealCancer #SurgicalOncology #MedOnc @cityofhope @CedarsSinai @TNOncology
#Myth or #Fact… "Survival for metastatic breast cancer has improved over recent decades."
#MetastaticBreastCancer #BreastCancerAwareness #ThinkPink #BackTable
BackTable Tumor Board retweeted
How does prior radiation turn a neck biopsy into a technical puzzle?
Dr. Majid Khan (@MajidKhan_spine) and Dr. Junjian Huang (@junjian_huang) join Dr. Neil Jain (@DigitalAngio) to share their approach for navigating trismus, carotid proximity, and drilling through sclerotic bone when standard techniques fall short.
Access the full episode in the BackTable app:
backtable.com/shows/vi/podca…
This podcast is supported by Varian OmniBone.
#VI672 #MSK112 #BoneBiopsy #PoweredAccess #SpineBiopsy #HeadAndNeck @NJIRSociety @JohnsHopkinsIR @EmoryIRad
How do you approach multifocal HCC in a patient without underlying cirrhosis?
This week’s Case Highlight features Drs. Gabriel Schnickel, Adam Burgoyne, Heather Patton (@Pattonhm1), Siddharth Padia (@SidpadiaIR), and Zach Berman (@ZTBerman) discussing treatment considerations for multifocal hepatocellular carcinoma in a non-cirrhotic patient.
Explore this case and more clinical discussions in the BackTable App: backtable.com/shows/tumor-bo…
#HCC #LiverCancer #InterventionalOncology #HepatobiliarySurgery @UCSDsurgery @RadiologyUcla @ucsd_IR
BackTable Tumor Board retweeted
I’m grateful @theNCI R50 grant allows me to continue to attend #NCTN @SWOG group meetings. It also grants me the opportunity to interact w/ junior faculty members such as @ronanhsieh @DaniCastilloMD #EmersonChen #IIT #cancer #cancerresearch concepts! @HKennecke @VanMorrisMD @lisakachnic1 @NCIDirector
BackTable Tumor Board retweeted
Shifting from a default biopsy approach to a reflex test and MRI-first strategy could dramatically lower unnecessary procedures.
Dr. Tarik Benidir (@TarikBenidir) and Dr. Ruchika Talwar (@RuchikaTalwarMD) explain how this new workflow streamlines care and improves outcomes for both clinicians and patients.
Access the full episode in the BackTable app: backtable.com/shows/urology/…
This podcast is supported by Cleveland Diagnostics.
#URO325 #ProstateCancer #PSA #ProstateBiopsy #UrologicOncology @UF_Urology @VUMChealth
BackTable Tumor Board retweeted
So great to see friends and mentors at #SWOG! Thankful for the guidance, inspiration, and friendships that make this community so special. #Oncology #CancerResearch @ronanhsieh @jgong15 @CathyEngMD @montypal @_backtableONC
BackTable Tumor Board retweeted
Won’t be quitting our day jobs 😎but what an experience walking #TheBlueJacketFashionShow LA for a great cause supporting #prostatecancer awareness👏🙌
With coverage by
@LAmag
lamag.com/philanthropy/our-p…
@_TheKnockturnal
theknockturnal.com/inside-th…
@ABC7
abc7.com/tag/fashion-show/
Knowledge is power 💪🏼💗🎗️ #ThinkPink #BreastCancerAwareness
Explore the #playlist in the #BackTable App, and let us know your favorite below! ⬇️
backtable.com/playlists/2f71…
Shout out to a couple of our fantastic guests! @barbaraobrienmd @ErikaHamilton9
BackTable Tumor Board retweeted
Arguably where the highest unmet need remains 🟰 refractory, unselected MSS mCRC. Key insight in this @_backtableONC ep from @IbrahimSahinMD1 @UMRogelCancer & @AlgazeMD @uscnorris❗️
@OncoAlert @AaronFrittsMD @_backtable @_backtableIND @ronanhsieh @DaniCastilloMD @_backtableENT
Third-line MSS colorectal cancer remains a high unmet need, but the options are growing.
Drs. Jun Gong (@jgong15), Ibrahim Sahin (@IbrahimSahinMD1) and Sandra Algaze (@AlgazeMD) on rechallenge strategies, STELLAR-303, botensilimab plus balstilimab, and the ADCs coming next. 🧬
Tune in now with the BackTable App: backtable.com/shows/tumor-bo…
#ONC84 #ColorectalCancer #GIOncology #MSSCRC @CedarsSinai @UMRogelCancer @ASCO @myESMO
Third-line MSS colorectal cancer remains a high unmet need, but the options are growing.
Drs. Jun Gong (@jgong15), Ibrahim Sahin (@IbrahimSahinMD1) and Sandra Algaze (@AlgazeMD) on rechallenge strategies, STELLAR-303, botensilimab plus balstilimab, and the ADCs coming next. 🧬
Tune in now with the BackTable App: backtable.com/shows/tumor-bo…
#ONC84 #ColorectalCancer #GIOncology #MSSCRC @CedarsSinai @UMRogelCancer @ASCO @myESMO